ISSN: 2212-5345

Journal Home

Journal Guideline

Respiratory Investigation Q2 Unclaimed

Elsevier B.V. Netherlands

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Respiratory Investigation is a journal indexed in SJR in Pulmonary and Respiratory Medicine with an H index of 40. It has an SJR impact factor of 0,66 and it has a best quartile of Q2. It has an SJR impact factor of 0,66.

Type: Journal

Type of Copyright:

Languages:

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Pulmonary and Respiratory Medicine (Q2)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

0,66

SJR Impact factor

40

H Index

109

Total Docs (Last Year)

312

Total Docs (3 years)

3228

Total Refs

705

Total Cites (3 years)

271

Citable Docs (3 years)

2.11

Cites/Doc (2 years)

29.61

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Annals of Allergy, Asthma and Immunology Q2
Journal of Asthma and Allergy Q2
Current Opinion in Pulmonary Medicine Q2
Chronic Obstructive Pulmonary Diseases Q2
Neurobiology of Sleep and Circadian Rhythms Q2

Compare this journals

Aims and Scope

Best articles by citations

Community-acquired necrotizing pneumonia with bacteremia caused by Pseudomonas aeruginosa in a patient with emphysema: An autopsy case report

Use of vasodilators for the treatment of pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis: A systematic review

Challenges in lung transplantation in Japan

Lung transplant candidates with idiopathic pulmonary fibrosis and long-term pirfenidone therapy: Treatment feasibility influences waitlist survival

Current status and future perspectives of cooperative study groups for lung cancer in Japan

A new diagnostic approach for bilious pleural effusion

MicroRNAs in pulmonary sarcoidosis: A systematic review

Cancer immunotherapy as a promising fourth standard therapy for lung cancer: Beyond 20 years for the development of immunotherapy

Direct hemoperfusion with polymyxin B-immobilized fiber for the treatment of the acute exacerbation of idiopathic pulmonary fibrosis in patients requiring invasive mechanical ventilation

Combination of assist use of short-acting beta-2 agonists inhalation and guidance based on patient-specific restrictions in daily behavior: Impact on physical activity of Japanese patients with chronic obstructive pulmonary disease

Current status and study activity of lung cancer in Japan

Definitions of disease: Should possible and probable idiopathic pulmonary fibrosis be enrolled in treatment trials?

SHOW MORE ARTICLES

Safety of Bronchoscopy for Patients Undergoing Hemodialysis

Cellular senescence and autophagy in the pathogenesis of chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis (IPF)

Respiratory medicine during the great East Japan earthquake and tsunami

Primary pleural hybrid cellular schwannoma/perineurioma: A case report

Stratifying the risk of COPD exacerbation using the modified Medical Research Council scale: A multicenter cross-sectional CAP study

Cigarette smoke augments MUC5AC production via the TLR3-EGFR pathway in airway epithelial cells

The updated classification of PVOD/PCH: A slight but meaningful change

A clinical method for detecting bronchial reversibility using a breath sound spectrum analysis in infants

DNA repair as an emerging target for COPD-lung cancer overlap

"The Long and Winding Road" seeking specific drugs for idiopathic pulmonary fibrosis

Febrile complications after endobronchial ultrasound-guided transbronchial needle aspiration for intra-pulmonary mass lesions of lung cancer - a series of 3 cases

Analysis of scrub typhus involvement of the lung by bronchoalveolar lavage: A case report